Xu Jiang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Squamous Cell Carcinoma

Top Venues

Pharmaceuticals (Basel, Switzerland)

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Xu Jiang, Kyung-Sang Yu, Dong Hyuk Nam, Jaeseong Oh
A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Xu Jiang, Kyung-Sang Yu, Dong Hyuk Nam, Jaeseong Oh
A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Xu Jiang, Sungyeun Bae, Deok Yong Yoon, Shin Jung Park, Jaeseong Oh, Joo-Youn Cho, Kyung-Sang Yu
Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects. Drug design, development and therapy 17 (2023)